ClinicalTrials.Veeva

Menu

Prenatal Diagnosis of the Fetal Esophageal or Intestinal Atresia (DANATRESIA)

P

Poitiers University Hospital

Status

Completed

Conditions

Antenatal Management of the Fetal Gastrointestinal Atresia

Treatments

Procedure: scheduled delivery at a tertiary center

Study type

Observational

Funder types

Other

Identifiers

NCT05362604
DANATRESIA

Details and patient eligibility

About

Aim- to investigate how prenatal diagnosis of fetal esophageal or intestinal atresia impacts obstetric and neonatal outcomes.

Methods- This was a retrospective cohort study at a single center. The study population comprised 51 consecutive pregnancies, including 29 mothers (57%) and their fetuses affected by prenatally diagnosed fetal esophageal or intestinal atresia, and 22 mothers (43%) and their babies with postnatally diagnosed fetal esophageal or intestinal atresia.

Full description

Aim- to investigate how prenatal diagnosis of fetal esophageal or intestinal atresia impacts obstetric and neonatal outcomes.

Methods- This was a retrospective cohort study at a single center. The study population comprised 51 consecutive participants, including 29 mothers (57%) and their fetuses affected by prenatally diagnosed fetal esophageal or intestinal atresia, and 22 mothers (43%) and their babies with postnatally diagnosed fetal esophageal or intestinal atresia.

Enrollment

51 patients

Sex

All

Ages

18 to 50 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • all pregnancies affected by fetal esophageal, duodenal or intestinal atresia referred to our prenatal diagnosis unit
  • all newborns managed for such atresia in our unit of pediatric surgery

Exclusion criteria

  • termination of pregnancy,
  • stillbirth,
  • the false positive cases

Trial design

51 participants in 2 patient groups

prenatal
Description:
patients affected by confirmed fetal esophageal, duodenal or intestinal atresia and followed in our high-risk pregnancy unit, and scheduled for delivery between 38 and 39 weeks in our tertiary center, regardless of the patient's place of residence
Treatment:
Procedure: scheduled delivery at a tertiary center
postnatal
Description:
patients with unsuspected fetal atresia who delivered in their local hospitals: their newborns were transferred to our tertiary hospital within 24 hours and the mother had the option to be also transferred in order to follow her baby.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems